ATF3 was reported overexpressed in glioma cohorts, and ATF3-knockdown was able to reduce the proliferative and invasive activity of glioma cell lines U373MG both in vitro and in vivo [29]. This evidence concerns the gene ATF3 and central nervous system cancer.